| Dawn Viers-yaun, LMFT, PHD | |
|
922 University City Blvd Ste 204, Blacksburg, VA 24060-2753 | |
| (540) 404-1339 | |
| (540) 739-3692 |
| Full Name | Dawn Viers-yaun |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 922 University City Blvd Ste 204, Blacksburg, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992276976 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 0717001521 (Virginia) | Primary |
| Entity Name | Dr. Dawn Viers Counseling, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184236903 PECOS PAC ID: 0345693917 Enrollment ID: O20240130003680 |
News Archive
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical trial of ARX-03, a proprietary sublingual dosage form combining an opioid, sufentanil, with a benzodiazepine, triazolam.
Multipotent fetal dermal cells (MFDCs) may be an ideal source for cell therapy for repairing damaged tissues and organs. Their performance is superior to that of adult dermal cells, said a research team in Italy that developed a cell isolation technique for MFDCs and subsequently published a study that appears as an early e-publication for the journal Cell Transplantation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Viers-yaun, LMFT, PHD 922 University City Blvd Ste 204, Blacksburg, VA 24060-2753 Ph: (540) 404-1339 | Dawn Viers-yaun, LMFT, PHD 922 University City Blvd Ste 204, Blacksburg, VA 24060-2753 Ph: (540) 404-1339 |
News Archive
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.
AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical trial of ARX-03, a proprietary sublingual dosage form combining an opioid, sufentanil, with a benzodiazepine, triazolam.
Multipotent fetal dermal cells (MFDCs) may be an ideal source for cell therapy for repairing damaged tissues and organs. Their performance is superior to that of adult dermal cells, said a research team in Italy that developed a cell isolation technique for MFDCs and subsequently published a study that appears as an early e-publication for the journal Cell Transplantation.
› Verified 9 days ago
Dr. Scott Johnson, PHD Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 920 Nellies Cave Rd, Blacksburg, VA 24060 Phone: 540-961-0328 | |
Dr. George Alan Willard, PH.D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1100 Highland Cir, Blacksburg, VA 24060 Phone: 540-808-3013 | |
James Tillett, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 840 University City Blvd Ste 10515, Blacksburg, VA 24060 Phone: 540-231-7201 | |
Melece Vida Meservy, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 315 Apartment Heights Dr Apt I12, Blacksburg, VA 24060 Phone: 808-478-0455 | |
Louis Anthony Lasprugato, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 110 Kinloch Dr, Blacksburg, VA 24060 Phone: 916-215-8451 | |
Dr. Carole M Mcnamee, PHD Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 200 Professional Park Dr Se Ste 3, Blacksburg, VA 24060 Phone: 540-449-4421 | |
Dr. Megan L Dolbin-macnab, PH.D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 840 University City Blvd, Suite 1, Blacksburg, VA 24060 Phone: 540-231-6807 Fax: 540-231-7209 |